Nuzenio

Director Amberjack Capital

Director Amberjack Capital news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 9 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Innovex International (NYSE:INVX) Director Amberjack Capital Partners, L. Sells 5,000,000 Shares - MarketBeatMarketBeat · Mon, 10 Aug 2026 23:10:31 GMTInnovex International (INVX) funds sell 5M shares at $28.71 in secondary - Stock TitanStock Titan · Mon, 10 Aug 2026 22:28:50 GMTConduent releases transcript of Q2 2026 earnings call - BitgetBitget · Mon, 10 Aug 2026 22:02:41 GMTInnovex International (INVX) insider funds net-sell 4.95M shares in secondary - Stock TitanStock Titan · Mon, 10 Aug 2026 21:50:29 GMTInnovex International Backs 5 Million-Share Secondary Offering at $28.71; Barclays Underwrites - TradingViewTradingView · Mon, 10 Aug 2026 20:53:01 GMTPoint2 collects $60M, Bernhard's $1B Bowman buy, Jazz's $820M epilepsy deal - AxiosAxios · Mon, 10 Aug 2026 19:23:51 GMTFlowserve Completes Sale of PMV Automation to Amberjack Capital Partners - marketscreener.commarketscreener.com · Mon, 10 Aug 2026 13:24:01 GMTAmberjack Capital Acquires PMV Automation From Flowserve to Drive Standalone Growth - citybizcitybiz · Mon, 10 Aug 2026 12:36:41 GMT

Timeline

Mon, 10 Aug 2026 23:10:31 GMTInnovex International (NYSE:INVX) Director Amberjack Capital Partners, L. Sells 5,000,000 Shares - MarketBeat
Mon, 10 Aug 2026 22:28:50 GMTInnovex International (INVX) funds sell 5M shares at $28.71 in secondary - Stock Titan
Mon, 10 Aug 2026 22:02:41 GMTConduent releases transcript of Q2 2026 earnings call - Bitget
Mon, 10 Aug 2026 21:50:29 GMTInnovex International (INVX) insider funds net-sell 4.95M shares in secondary - Stock Titan
Mon, 10 Aug 2026 20:53:01 GMTInnovex International Backs 5 Million-Share Secondary Offering at $28.71; Barclays Underwrites - TradingView
Mon, 10 Aug 2026 19:23:51 GMTPoint2 collects $60M, Bernhard's $1B Bowman buy, Jazz's $820M epilepsy deal - Axios

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Director Amberjack Capital.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.